Diroximel fumarate in the treatment of multiple sclerosis.

Neurodegenerative Disease Management
Elise Jonasson, Tobias Sejbaek

Abstract

Diroximel fumarate (DRF) is a new emerging therapy for patients with multiple sclerosis. The levels of its active metabolite, monomethyl fumarate, are bioequivalent to the levels generated from dimethyl fumarate (DMF) treatment. The efficacy and safety profiles of DRF are expected to be similar to the well-established profiles of DMF. The metabolism of DRF leads to lower concentration of methanol in the small intestine than with DMF and thus reduced severity and frequency of gastrointestinal adverse events. DRF seems a promising alternative to DMF and other first-line therapies for multiple sclerosis. The current review is based on the two existing Phase III trials of DRF: the interim analysis of the EVOLVE-MS-1 trial and the completed EVOLVE-MS-2 trial.

References

May 26, 1998·Journal of Neuropathology and Experimental Neurology·D GvericJ Newcombe
Jan 15, 2005·Trends in Molecular Medicine·Ulrich Mrowietz, Khusru Asadullah
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
Jan 22, 2010·The New England Journal of Medicine·Jeffrey A CohenUNKNOWN TRANSFORMS Study Group
Mar 11, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Joan BentzenNils Koch-Henriksen
Sep 15, 2011·International Journal of Dermatology·Angelo Massimiliano D'ErmeMassimo Gola
Oct 14, 2011·The New England Journal of Medicine·Paul O'ConnorUNKNOWN TEMSO Trial Group
Jan 24, 2012·The Journal of Pharmacology and Experimental Therapeutics·Robert H ScannevinKenneth J Rhodes
Sep 21, 2012·The New England Journal of Medicine·Robert J FoxUNKNOWN CONFIRM Study Investigators
Sep 21, 2012·The New England Journal of Medicine·Ralf GoldUNKNOWN DEFINE Study Investigators
Feb 13, 2013·Journal of Managed Care Pharmacy : JMCP·Joseph MenzinMichael W Pill
Jan 15, 2014·Sensors·Maria-Cristina RadulescuGabriel Lucian Radu
Apr 3, 2014·The Journal of Clinical Investigation·Hui ChenMarkus Schwaninger
May 6, 2014·Lancet Neurology·Peter A CalabresiUNKNOWN ADVANCE Study Investigators
Nov 6, 2014·Therapeutic Advances in Neurological Disorders·Kathrin S UtzThomas Schenk
Dec 8, 2015·Work : a Journal of Prevention, Assessment, and Rehabilitation·Malachy Bishop, Phillip D Rumrill
Apr 15, 2016·Proceedings of the National Academy of Sciences of the United States of America·Ulf Schulze-TopphoffScott S Zamvil
Dec 22, 2016·The New England Journal of Medicine·Stephen L HauserUNKNOWN OPERA I and OPERA II Clinical Investigators
Apr 22, 2017·Multiple Sclerosis and Related Disorders·Ruth Ann MarrieJohn D Fisk
Jun 28, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andrew L SmithLe H Hua
Jul 15, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Nils Koch-HenriksenMelinda Magyari
Oct 14, 2017·Annals of Occupational and Environmental Medicine·Chan-Seok Moon
Dec 15, 2017·Nature Reviews. Cardiology·Gregory B Lim
Jun 16, 2018·Multiple Sclerosis and Related Disorders·Tobias SejbaekZsolt Illes
Jun 22, 2018·Annals of Clinical and Translational Neurology·Anna HammerRalf A Linker
Jun 19, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Martin DieboldJohannes Lorscheider
Nov 5, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Robert T NaismithRichard Leigh-Pemberton

❮ Previous
Next ❯

Software Mentioned

IGISIS
EVOLVE
DEFINE
MS
CONFIRM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.